CYLD and neoplasm: A number of negative regulators of the NF-κB pathway such as the deubiquitinases (DUB) A20 (32) and CYLD (33), ubiquitin ligase SOCS-1 (19), and a group of miRNAs (34), etc., have been identified as tumor suppressors.